img

Global His-Tag Antibody Market Segment Research Report 2024


Published on: 2024-01-04 | No of Pages : 420 | Industry : Pharma & Healthcare Research Center

Publisher : MRX | Format : PDF

Global His-Tag Antibody Market Segment Research Report 2024

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global His-Tag Antibody Market Segment Research Report 2022》, which aims to sort out the development status and trends of the His-Tag Antibody industry at home and abroad, estimate the overall market scale of the His-Tag Antibody industry and the market share of major countries, His-Tag Antibody industry, and study and judge the downstream market demand of His-Tag Antibody through systematic research, Analyze the competition pattern of His-Tag Antibody, so as to help solve the pain points of various stakeholders in His-Tag Antibody industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of His-Tag Antibody Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in His-Tag Antibody Market?
Cell Signaling Technology
Aviva Systems Biology
OriGene
United States Biological
Santa Cruz Biotechnology
Proteintech
GeneTex
BioLegend
Bio X Cell
Medimabs
Columbia Biosciences
NSJ Bioreagents
Major Type of His-Tag Antibody Covered in XYZResearch report
Polyclonal
Monoclonal
Application Segments Covered in XYZResearch Market
Western Blot
Immunoprecipitation
Immunofluorescence
Others

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global His-Tag Antibody Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global His-Tag Antibody Market by Value
2.2.1 Global His-Tag Antibody Revenue by Type
2.2.2 Global His-Tag Antibody Market by Value (%)
2.3 Global His-Tag Antibody Market by Production
2.3.1 Global His-Tag Antibody Production by Type
2.3.2 Global His-Tag Antibody Market by Production (%)

3. The Major Driver of His-Tag Antibody Industry
3.1 Historical & Forecast Global His-Tag Antibody Demand
3.2 Largest Application for His-Tag Antibody (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional His-Tag Antibody Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of His-Tag Antibody Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US His-Tag Antibody Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe His-Tag Antibody Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China His-Tag Antibody Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan His-Tag Antibody Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India His-Tag Antibody Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea His-Tag Antibody Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia His-Tag Antibody Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global His-Tag Antibody Average Price Trend
12.1 Market Price for Each Type of His-Tag Antibody in US (2018-2022)
12.2 Market Price for Each Type of His-Tag Antibody in Europe (2018-2022)
12.3 Market Price for Each Type of His-Tag Antibody in China (2018-2022)
12.4 Market Price for Each Type of His-Tag Antibody in Japan (2018-2022)
12.5 Market Price for Each Type of His-Tag Antibody in India (2018-2022)
12.6 Market Price for Each Type of His-Tag Antibody in Korea (2018-2022)
12.7 Market Price for Each Type of His-Tag Antibody in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 His-Tag Antibody Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of His-Tag Antibody

14. His-Tag Antibody Competitive Landscape
14.1 Cell Signaling Technology
14.1.1 Cell Signaling Technology Company Profiles
14.1.2 Cell Signaling Technology Product Introduction
14.1.3 Cell Signaling Technology His-Tag Antibody Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Aviva Systems Biology
14.2.1 Aviva Systems Biology Company Profiles
14.2.2 Aviva Systems Biology Product Introduction
14.2.3 Aviva Systems Biology His-Tag Antibody Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 OriGene
14.3.1 OriGene Company Profiles
14.3.2 OriGene Product Introduction
14.3.3 OriGene His-Tag Antibody Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 United States Biological
14.4.1 United States Biological Company Profiles
14.4.2 United States Biological Product Introduction
14.4.3 United States Biological His-Tag Antibody Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Santa Cruz Biotechnology
14.5.1 Santa Cruz Biotechnology Company Profiles
14.5.2 Santa Cruz Biotechnology Product Introduction
14.5.3 Santa Cruz Biotechnology His-Tag Antibody Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Proteintech
14.6.1 Proteintech Company Profiles
14.6.2 Proteintech Product Introduction
14.6.3 Proteintech His-Tag Antibody Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 GeneTex
14.7.1 GeneTex Company Profiles
14.7.2 GeneTex Product Introduction
14.7.3 GeneTex His-Tag Antibody Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 BioLegend
14.8.1 BioLegend Company Profiles
14.8.2 BioLegend Product Introduction
14.8.3 BioLegend His-Tag Antibody Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Bio X Cell
14.9.1 Bio X Cell Company Profiles
14.9.2 Bio X Cell Product Introduction
14.9.3 Bio X Cell His-Tag Antibody Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Medimabs
14.10.1 Medimabs Company Profiles
14.10.2 Medimabs Product Introduction
14.10.3 Medimabs His-Tag Antibody Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Columbia Biosciences
14.12 NSJ Bioreagents
15. Conclusion
16. Methodology and Data Source


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of His-Tag Antibody Industry (Volume)
Figure 2. His-Tag Antibody Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by His-Tag Antibody Revenue in 2022
Figure 5. US His-Tag Antibody Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe His-Tag Antibody Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China His-Tag Antibody Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan His-Tag Antibody Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India His-Tag Antibody Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea His-Tag Antibody Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia His-Tag Antibody Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. His-Tag Antibody Revenue, by Type (Million USD) (2018-2028)
Table 4. His-Tag Antibody Production, by Type (K Unit) (2018-2028)
Table 5. His-Tag Antibody Demand (K Unit) by Application (2018-2028)
Table 6. His-Tag Antibody Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top His-Tag Antibody Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US His-Tag Antibody Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe His-Tag Antibody Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China His-Tag Antibody Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan His-Tag Antibody Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India His-Tag Antibody Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea His-Tag Antibody Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia His-Tag Antibody Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of His-Tag Antibody in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of His-Tag Antibody in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of His-Tag Antibody in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of His-Tag Antibody in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of His-Tag Antibody in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of His-Tag Antibody in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of His-Tag Antibody in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Cell Signaling Technology Profiles
Table 61. Cell Signaling Technology His-Tag Antibody Product Introduction
Table 62. Cell Signaling Technology His-Tag Antibody Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Cell Signaling Technology Strategic initiatives
Table 64. Aviva Systems Biology Profiles
Table 65. Aviva Systems Biology His-Tag Antibody Product Introduction
Table 66. Aviva Systems Biology His-Tag Antibody Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Aviva Systems Biology Strategic initiatives
Table 68. OriGene Profiles
Table 69. OriGene His-Tag Antibody Product Introduction
Table 70. OriGene His-Tag Antibody Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. OriGene Strategic initiatives
Table 72. United States Biological Profiles
Table 73. United States Biological His-Tag Antibody Product Introduction
Table 74. United States Biological His-Tag Antibody Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. United States Biological Strategic initiatives
Table 76. Santa Cruz Biotechnology Profiles
Table 77. Santa Cruz Biotechnology His-Tag Antibody Product Introduction
Table 78. Santa Cruz Biotechnology His-Tag Antibody Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Santa Cruz Biotechnology Strategic initiatives
Table 80. Proteintech Profiles
Table 81. Proteintech His-Tag Antibody Product Introduction
Table 82. Proteintech His-Tag Antibody Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Proteintech Strategic initiatives
Table 84. GeneTex Profiles
Table 85. GeneTex His-Tag Antibody Product Introduction
Table 86. GeneTex His-Tag Antibody Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. GeneTex Strategic initiatives
Table 88. BioLegend Profiles
Table 89. BioLegend His-Tag Antibody Product Introduction
Table 90. BioLegend His-Tag Antibody Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. BioLegend Strategic initiatives
Table 92. Bio X Cell Profiles
Table 93. Bio X Cell His-Tag Antibody Product Introduction
Table 94. Bio X Cell His-Tag Antibody Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Bio X Cell Strategic initiatives
Table 97. Medimabs Profiles
Table 98. Medimabs His-Tag Antibody Product Introduction
Table 99. Medimabs His-Tag Antibody Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Medimabs Strategic initiatives
Table 101. Columbia Biosciences Profiles
Table 102. Columbia Biosciences His-Tag Antibody Product Introduction
Table 103. Columbia Biosciences His-Tag Antibody Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Columbia Biosciences Strategic initiatives
Table 105. NSJ Bioreagents Profiles
Table 106. NSJ Bioreagents His-Tag Antibody Product Introduction
Table 107. NSJ Bioreagents His-Tag Antibody Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. NSJ Bioreagents Strategic initiatives